Given the ambiguity of VHL mutation status versus response to ICIs, one study looked at serum levels of the effector cytokine VEGFα and identified an association between increased VEGFα and poor response to ICIs in melanoma [145]. This evidence concerns the gene VEGFA and melanoma.